Table 2 Prescription pattern of medications for atrial fibrillation according to the degree of left atrial enlargement by left atrial anterior–posterior dimension.
From: Clinical impact of left atrial enlargement in Korean patients with atrial fibrillation
Baseline characteristics | Overall | No LAE | Mild LAE | Moderate LAE | Severe LAE | P-value |
|---|---|---|---|---|---|---|
(n = 8159) | (n = 2402) | (n = 2499) | (n = 1511) | (n = 1747) | ||
Anticoagulation | 5836 (71.5) | 1368 (57.0) | 1761 (70.5) | 1218 (80.6) | 1489 (85.2) | < 0.001 |
Warfarin | 1264 (15.5) | 224 (9.3) | 350 (14.0) | 265 (17.5) | 425 (24.3) | < 0.001 |
NOAC | 4752 (58.2) | 1183 (49.3) | 1450 (58.0) | 994 (65.8) | 1125 (64.4) | < 0.001 |
Antiplatelets | 1854 (22.7) | 614 (25.6) | 611 (24.4) | 305 (20.2) | 324 (18.5) | < 0.001 |
Antiarrhythmics | 3812 (46.7) | 1414 (58.9) | 1254 (50.2) | 664 (43.9) | 480 (27.5) | < 0.001 |
Class I | 2726 (33.4) | 1093 (45.5) | 914 (36.6) | 434 (28.7) | 285 (16.3) | < 0.001 |
Class III | 1261 (15.5) | 363 (15.1) | 398 (15.9) | 268 (17.7) | 232 (13.3) | < 0.001 |
Others | ||||||
Beta-blocker | 4177 (51.2) | 1181 (49.2) | 1234 (49.4) | 794 (52.5) | 968 (55.4) | < 0.001 |
Calcium channel blocker | 2263 (27.8) | 545 (22.7) | 710 (28.4) | 460 (30.4) | 548 (31.4) | < 0.001 |
Digoxin | 571 (7.0) | 74 (3.1) | 132 (5.3) | 128 (8.5) | 237 (13.6) | < 0.001 |
